EMA as well as FDA recently designated PureIMS’s colistin dry powder inhaler ‘Colistin Cyclops®’ orphan drug product for the treatment of cystic fibrosis.   Colistin Cyclops® is an orally inhaled antibiotic used for treating (chronic) Pseudomonas aeruginosa infections of the lungs. Despite the transformative potential of CFTR modulators in addressing the root causes of cystic fibrosis, […]